Remove Academic Remove Biomarkers Remove Echocardiogram
article thumbnail

ACE Inhibitor Not Protective Against Heart Damage from Chemotherapy

DAIC

The PROACT study reported no impact on cardiotoxicity biomarkers or secondary endpoints related to heart function among patients who took high doses of enalapril, an ACE inhibitor, along with high doses of anthracyclines.

article thumbnail

Occlusion myocardial infarction is a clinical diagnosis

Dr. Smith's ECG Blog

The ESC states that patients with suspected ACS should go to the cath lab in <2 hours "regardless of ECG or biomarker evidence of MI!!" Her contrast enhanced echocardiogram is shown below in the parasternal short axis view. Academic Emergency Medicine 27(S1): S220; May 2020. The patient suffered a large infarct. Abstract 556.